Quick Answer
IDEAYA Biosciences, Inc. reported Diluted EPS of $1.28 per share (loss) for fiscal year 2025.
IDEAYA Biosciences, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.28 | +61.9% |
| 2024 | -$3.36 | -71.4% |
| 2023 | -$1.96 | -38.0% |
| 2022 | -$1.42 | -0.7% |
| 2021 | -$1.41 | -0.7% |
| 2020 | -$1.40 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.33 | +321.7% | +251.1% |
| June 30, 2025 | -$0.88 | -29.4% | -7.3% |
| March 31, 2025 | -$0.82 | -54.7% | -36.7% |
| September 30, 2024 | -$0.60 | -30.4% | +11.8% |
| June 30, 2024 | -$0.68 | -36.0% | -28.3% |
| March 31, 2024 | -$0.53 | -8.2% | -15.2% |
| September 30, 2023 | -$0.46 | -1250.0% | +8.0% |
| June 30, 2023 | -$0.50 | +12.3% | -2.0% |
- IDEAYA Biosciences, Inc. showed an increase of +61.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, IDEAYA Biosciences, Inc.’s diluted eps has grown by 8.6% (from $1.40 per share (loss) to $1.28 per share (loss)).
- The most recent figure is from IDEAYA Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: